NIH PAR · NHLBI · R34
PAR-25-032: NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
This Notice of Funding Opportunity Announcement (NOFO) intends to supports studies that are both necessary and sufficient to inform the planning of a Phase II-IV clinical trial within NHLBI's mission. The NHLBI expects that applications to this NOFO will describe the planned clinical trial and in so doing demonstrate that the proposed (R34) research is scientifically necessary to design or plan the subsequent trial. Furthermore, this NOFO will support research projects that are designed to provide results that will be sufficient to inform the future trial without further studies. The planned Phase II, III, or IV trial must be primarily intended to test the efficacy, safety, clinical…
- NOFO number
- PAR-25-032
- Type
- PAR
- Activity code
- R34
- Primary institute
- NHLBI · National Heart, Lung, and Blood Institute
- Clinical trials
- Optional
- Posted
- Dec 18, 2024
- Opens
- Jan 16, 2025
- Expires
- Jan 8, 2027
PAR-25-032 due dates
1 application due date remains before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| February 16, 2025 | March 16, 2025 * | May 07, 2025 * | July 2025 | October 2025 | December 2025 |
| June 16, 2025 | July 16, 2025 * | September 07, 2025 * | November 2025 | January 2026 | April 2026 |
| October 16, 2025 | November 16, 2025 * | January 07, 2026 * | March 2026 | May 2026 | July 2026 |
| February 16, 2026 | March 16, 2026 * | May 07, 2026 * | July 2026 | October 2026 | December 2026 |
| June 16, 2026 | July 16, 2026 * | Not Applicable | November 2026 | January 2027 | April 2027 |
| October 16, 2026 | November 16, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
Projects funded under PAR-25-032
NIH RePORTER lists 20 projects funded under PAR-25-032 in FY2022–FY2026, with $5.6M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
20
Distinct projects, FY2022–FY2026
New awards
20
Type 1 (new project) award records
NIH funding
$5.6M
Award dollars under PAR-25-032, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 20 | 20 | $5.6M |
Institutions with the most funding
- Univ of Massachusetts Med Sch Worcester$745K · 1 project
- University of Mississippi Med Ctr$333K · 1 project
- University of Colorado Denver$304K · 1 project
- University of Virginia$284K · 1 project
- Sloan-Kettering Inst Can Research$282K · 1 project
- Yale University$279K · 1 project
- Trustees of Indiana University$277K · 1 project
- Washington University$272K · 1 project
Funding institutes
- NHLBI$5.6M · 20
Activity codes funded
- R3420 records
Most recent new awards
- Leveraging Incidental Findings from Low-Dose CT to Enhance COPD Detection (opens NIH RePORTER)
Icahn School of Medicine at Mount Sinai · 1R34HL183471-01A1 · NHLBI · Notice Sep 17, 2026
$210KR34
- Evaluation of an Adaptive Lifestyle Intervention for Adults with Type 1 Diabetes (opens NIH RePORTER)
Yale University · 1R34HL183466-01A1 · NHLBI · Notice Sep 17, 2026
$279KR34
- Evaluating patient performance of postoperative incentive spirometry (opens NIH RePORTER)
University of Colorado Denver · 1R34HL186281-01 · NHLBI · Notice Sep 11, 2026
$304KR34
- Pilot Trial Evaluating a Mechanical Power Targeted Ventilation Strategy in Adult VV ECMO Patients with Severe ARDS (opens NIH RePORTER)
University of Virginia · 1R34HL186224-01 · NHLBI · Notice Sep 10, 2026
$284KR34
- Developing customizable, feasible, and efficient infant-tailored diet assessment methods (opens NIH RePORTER)
Pennsylvania State University, the · 1R34HL188567-01 · NHLBI · Notice Sep 3, 2026
$251KR34
- Pilot Trial of Physical Activity Partnerships for Women in Midlife with Elevated Risk for Cardiovascular Disease (opens NIH RePORTER)
Rowan University · 1R34HL189015-01 · NHLBI · Notice Sep 1, 2026
$271KR34
What its predecessor PAR-24-049 funded
PAR-25-032 reissues PAR-24-049. Its funding history is the best guide to who wins under this program: 14 projects and $8.7M in FY2022–FY2026.
Projects funded
14
Distinct projects, FY2022–FY2026
New awards
14
Type 1 (new project) award records
NIH funding
$8.7M
Award dollars under PAR-24-049, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 14 | 14 | $4.5M |
| FY2026 | 14 | 0 | $4.2M |
Institutions with the most funding
- University of California, San Francisco$1.4M · 2 projects
- Columbia University Health Sciences$790K · 1 project
- New York University School of Medicine$778K · 1 project
- University of Texas Hlth Science Center$755K · 1 project
- Cleveland Clinic Lerner Com-Cwru$725K · 1 project
- George Washington University$713K · 1 project
- Medical University of South Carolina$698K · 1 project
- Brigham and Women's Hospital$549K · 1 project
Funding institutes
- NHLBI$8.7M · 28
Activity codes funded
- R3428 records
Most recent new awards
- Rescue anakinra treatment for moderate asthma attacks (opens NIH RePORTER)
Univ of North Carolina Chapel Hill · 1R34HL179910-01 · NHLBI · Notice Sep 15, 2025
$233KR34
- Integrated Intervention for Depression and Asthma Self-management in Older Adults (opens NIH RePORTER)
Icahn School of Medicine at Mount Sinai · 1R34HL179141-01 · NHLBI · Notice Sep 15, 2025
$260KR34
- Bilevel positive airway pressure (BPAP) for severe pediatric asthma exacerbations: A randomized, controlled trial. (opens NIH RePORTER)
Columbia University Health Sciences · 1R34HL173384-01A1 · NHLBI · Notice Sep 13, 2025
$427KR34
- Antihypertensive self-titration to improve US blood pressure control (opens NIH RePORTER)
Brigham and Women's Hospital · 1R34HL178960-01 · NHLBI · Notice Aug 21, 2025
$285KR34
- Feasibility and Acceptability of A Mobile Application "SUPPORT-T" to increase access of Palliative Care in patients with Progressive Pulmonary Fibrosis (PPF) and their caregivers (opens NIH RePORTER)
Medical University of South Carolina · 1R34HL174722-01A1 · NHLBI · Notice Aug 18, 2025
$356KR34
- Democratizing Access to Cleaner Residential Air (DACRA) (opens NIH RePORTER)
University of Connecticut Sch of Med/Dnt · 1R34HL173375-01A1 · NHLBI · Notice Aug 14, 2025
$293KR34
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under PAR-25-032. Contact the program officer at the institute that fits your research before applying.
- NHLBI · National Heart, Lung, and Blood Institute
- none
Related notices
Mar 31, 2025 · NOT-OD-24-084
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25,…
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Award terms
- Application types allowed
- NewResubmissionRevision The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets may request up to 450,000 in direct costs over a three-year period. Application budgets may request up to 225,000 in direct costs in any single year.
- Project period
- The maximum project period is 3 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-24-049.
Other open NOFOs for R34
- PAR-25-358NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)NEI · next due Oct 16, 2026
- PAR-24-329Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)NIDA · next due Oct 16, 2026
- PAR-25-284Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)NIMH · next due Oct 16, 2026
- PAR-25-100Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)NIDA · next due Oct 16, 2026
- PAR-25-159Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)NIAAA · next due Oct 16, 2026
- PAR-25-288Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required)NIMH · next due Oct 16, 2026
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.